Comprehensive metabolic panel (CMP) testing is a blood test that measures body’s fluid balance and electrolyte levels and tests functions of kidney and liver.
Comprehensive Metabolic Panel (CMP) Testing: Essential Blood Test for Metabolic Function Measurement
- Comprehensive metabolic panel (CMP) testing is a blood test that measures body’s fluid balance and electrolyte levels and tests functions of kidney and liver
- CMP testing measures 14 different substances in one’s blood for metabolism check and is used for assessing different conditions such as liver and kidney health, blood sugar level, blood protein level, acid base balance, and fluid and electrolyte balance
Read Report Overview - https://www.transparencymarketresearch.com/comprehensive-metabolic-panel-testing-market.html
- This test is a preliminary test and its results indicate liver diseases, kidney failure, or diabetes. Most blood tests take just a few minutes and patients are advised 10 to 12 hours fast for proper test results.
- This test is a part of regular health examination and measures albumin, blood urea nitrogen, calcium, carbon dioxide, chloride, creatinine, glucose, potassium, sodium, total bilirubin, total protein, alanine aminotransferase, alkaline phosphatase, and aspartate aminotransferase.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74363
Key Drivers and Restraints of Global Comprehensive Metabolic Panel (CMP) Testing Market
- Rise in prevalence of chronic diseases such as kidney diseases, diabetes, and liver diseases and emphasis of people on early diagnosis of these diseases are some of the factors responsible for the growth of the global comprehensive metabolic panel (CMP) testing market
- For instance, as per National Institute of Diabetes and Digestive and Kidney Diseases (U.S. Department of Health and Human Services), the overall prevalence of chronic kidney disease (CKD) increased from 12% to 14% between 1988 and 1994 and from 1999 to 2004 in the U.S.
- Changing lifestyle habits such as smoking and changing food habits have contributed toward obesity, stress, and other conditions which can lead to increase in chronic diseases, thereby propelling the global comprehensive metabolic panel (CMP) testing market
- Rise in demand of point-of-care testing for early detection and faster results by these tests are some of the factors responsible for the growth of global comprehensive metabolic panel (CMP) testing market
Unskilled Staff for Handling Procedure to Hamper Market
- CMP testing needs qualified and well-trained staff for proper handling of the procedure. If the staff is unskilled, then it can lead to injuries. This, in turn, is anticipated to restrain the market. Also, sometimes CMP testing creates false results which can hamper the market growth.
- Stringent regulations by regulatory authorities are expected to hinder the growth of the global comprehensive metabolic panel (CMP) testing market
Request for Analysis of COVID-19 Impact on Comprehensive Metabolic Panel (CMP) Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74363
Diabetes Segment to be Highly Lucrative Segment
- Based on disease, the global comprehensive metabolic panel (CMP) testing market can be segmented into kidney diseases, liver diseases, diabetes, and others
- The kidney diseases segment held major market share in 2018, owing to high prevalence of kidney diseases across the globe, rise in awareness regarding renal diseases, and emphasis of people on early diagnosis
- The diabetes segment is projected to be a highly promising segment during the forecast period, due to changing lifestyle habits and increase in prevalence of diabetes in all parts of the world.
Kidney Tests Segment Dominated Global Market
- In terms of test type, global comprehensive metabolic panel (CMP) testing market can be divided into electrolytes, proteins, kidney tests, glucose, liver functional tests, and others
- The kidney tests segment dominated the global market in 2018. Rise in prevalence of kidney diseases, rise in patients suffering from cardiovascular & diabetes with further chance of kidney diseases, and rise in demand of kidney tests in geriatric population are some of the major factors responsible for the growth of this segment
PoC to be More Promising End-user Segment
- Based on end-user, the global comprehensive metabolic panel (CMP) testing market can be bifurcated into laboratories and PoC (Point-of-Care)
- Laboratories are expected to dominate the global market owing to increase in usage of diagnostic tests at these laboratories, higher number of laboratories availability, and easy accessibility of these laboratories
- PoC is anticipated to be a highly promising segment during the forecast period. Patient convenience, portability, and speedy results are some of the major factors responsible for the growth of this segment.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=74363
North America to Lead Global Comprehensive Metabolic Panel (CMP) Testing Market
- In terms of region, the global comprehensive metabolic panel (CMP) testing market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global comprehensive metabolic panel (CMP) testing market in 2018, owing to higher prevalence of chronic diseases, advanced health care infrastructure, presence of major players, and growing emphasis of people on early diagnosis of diseases
- For instance, as per the American Diabetes Association, in 2015, around 30.3 million population in the U.S. had diabetes which was around 9.4% of the total population in the U.S.
- The comprehensive metabolic panel (CMP) testing market in Asia Pacific is projected to expand at a higher CAGR during the forecast period, owing to increase in geriatric population which is more prone to chronic diseases, higher prevalence of diabetes in emerging countries, rise in awareness of early diagnosis of diseases, and improving health care infrastructure
Key Manufacturers Operating in Global Market
Key manufacturers operating in the global comprehensive metabolic panel (CMP) testing market are:
- Abbott Laboratories
- Quest Diagnostics Incorporated
- Sonic Healthcare
- Laboratory Corporation of America Holdings
- ARUP Laboratories
- CENTOGENE AG
- SYNLAB International GmbH
- TCG Corp
- Scion Lab Services, LLC
- UNIPATH
Browse more Reports by Transparency Market Research:
Gelatin Capsules Market: Rise in adoption of unhealthy lifestyles by urban consumers worldwide, particularly in developed areas, has fueled the demand for nutraceuticals, which is expected to be a key driver of the global gelatin capsules market in the coming years. Aside from nutraceuticals, expansion of the pharmaceutical industry into the cosmeceuticals sector offers significant opportunity for the gelatin capsules market.
Urinalysis Market: The urinalysis market in North America is expected to grow at a rapid pace in the coming years. There has been a tremendous increase in the use of urine analysis and has become a part of any general health check up in the past decade. Increasing research activities in the field of urinalysis and growing awareness of personalized medicine have also resulted in the establishment point of care systems.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
Comprehensive Metabolic Panel (CMP) Testing: Essential Blood Test for Metabolic Function Measurement
- Comprehensive metabolic panel (CMP) testing is a blood test that measures body’s fluid balance and electrolyte levels and tests functions of kidney and liver
- CMP testing measures 14 different substances in one’s blood for metabolism check and is used for assessing different conditions such as liver and kidney health, blood sugar level, blood protein level, acid base balance, and fluid and electrolyte balance
Read Report Overview - https://www.transparencymarketresearch.com/comprehensive-metabolic-panel-testing-market.html
- This test is a preliminary test and its results indicate liver diseases, kidney failure, or diabetes. Most blood tests take just a few minutes and patients are advised 10 to 12 hours fast for proper test results.
- This test is a part of regular health examination and measures albumin, blood urea nitrogen, calcium, carbon dioxide, chloride, creatinine, glucose, potassium, sodium, total bilirubin, total protein, alanine aminotransferase, alkaline phosphatase, and aspartate aminotransferase.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74363
Key Drivers and Restraints of Global Comprehensive Metabolic Panel (CMP) Testing Market
- Rise in prevalence of chronic diseases such as kidney diseases, diabetes, and liver diseases and emphasis of people on early diagnosis of these diseases are some of the factors responsible for the growth of the global comprehensive metabolic panel (CMP) testing market
- For instance, as per National Institute of Diabetes and Digestive and Kidney Diseases (U.S. Department of Health and Human Services), the overall prevalence of chronic kidney disease (CKD) increased from 12% to 14% between 1988 and 1994 and from 1999 to 2004 in the U.S.
- Changing lifestyle habits such as smoking and changing food habits have contributed toward obesity, stress, and other conditions which can lead to increase in chronic diseases, thereby propelling the global comprehensive metabolic panel (CMP) testing market
- Rise in demand of point-of-care testing for early detection and faster results by these tests are some of the factors responsible for the growth of global comprehensive metabolic panel (CMP) testing market
Unskilled Staff for Handling Procedure to Hamper Market
- CMP testing needs qualified and well-trained staff for proper handling of the procedure. If the staff is unskilled, then it can lead to injuries. This, in turn, is anticipated to restrain the market. Also, sometimes CMP testing creates false results which can hamper the market growth.
- Stringent regulations by regulatory authorities are expected to hinder the growth of the global comprehensive metabolic panel (CMP) testing market
Request for Analysis of COVID-19 Impact on Comprehensive Metabolic Panel (CMP) Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=74363
Diabetes Segment to be Highly Lucrative Segment
- Based on disease, the global comprehensive metabolic panel (CMP) testing market can be segmented into kidney diseases, liver diseases, diabetes, and others
- The kidney diseases segment held major market share in 2018, owing to high prevalence of kidney diseases across the globe, rise in awareness regarding renal diseases, and emphasis of people on early diagnosis
- The diabetes segment is projected to be a highly promising segment during the forecast period, due to changing lifestyle habits and increase in prevalence of diabetes in all parts of the world.
Kidney Tests Segment Dominated Global Market
- In terms of test type, global comprehensive metabolic panel (CMP) testing market can be divided into electrolytes, proteins, kidney tests, glucose, liver functional tests, and others
- The kidney tests segment dominated the global market in 2018. Rise in prevalence of kidney diseases, rise in patients suffering from cardiovascular & diabetes with further chance of kidney diseases, and rise in demand of kidney tests in geriatric population are some of the major factors responsible for the growth of this segment
PoC to be More Promising End-user Segment
- Based on end-user, the global comprehensive metabolic panel (CMP) testing market can be bifurcated into laboratories and PoC (Point-of-Care)
- Laboratories are expected to dominate the global market owing to increase in usage of diagnostic tests at these laboratories, higher number of laboratories availability, and easy accessibility of these laboratories
- PoC is anticipated to be a highly promising segment during the forecast period. Patient convenience, portability, and speedy results are some of the major factors responsible for the growth of this segment.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=74363
North America to Lead Global Comprehensive Metabolic Panel (CMP) Testing Market
- In terms of region, the global comprehensive metabolic panel (CMP) testing market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America dominated the global comprehensive metabolic panel (CMP) testing market in 2018, owing to higher prevalence of chronic diseases, advanced health care infrastructure, presence of major players, and growing emphasis of people on early diagnosis of diseases
- For instance, as per the American Diabetes Association, in 2015, around 30.3 million population in the U.S. had diabetes which was around 9.4% of the total population in the U.S.
- The comprehensive metabolic panel (CMP) testing market in Asia Pacific is projected to expand at a higher CAGR during the forecast period, owing to increase in geriatric population which is more prone to chronic diseases, higher prevalence of diabetes in emerging countries, rise in awareness of early diagnosis of diseases, and improving health care infrastructure
Key Manufacturers Operating in Global Market
Key manufacturers operating in the global comprehensive metabolic panel (CMP) testing market are:
- Abbott Laboratories
- Quest Diagnostics Incorporated
- Sonic Healthcare
- Laboratory Corporation of America Holdings
- ARUP Laboratories
- CENTOGENE AG
- SYNLAB International GmbH
- TCG Corp
- Scion Lab Services, LLC
- UNIPATH
Browse more Reports by Transparency Market Research:
Gelatin Capsules Market: Rise in adoption of unhealthy lifestyles by urban consumers worldwide, particularly in developed areas, has fueled the demand for nutraceuticals, which is expected to be a key driver of the global gelatin capsules market in the coming years. Aside from nutraceuticals, expansion of the pharmaceutical industry into the cosmeceuticals sector offers significant opportunity for the gelatin capsules market.
Urinalysis Market: The urinalysis market in North America is expected to grow at a rapid pace in the coming years. There has been a tremendous increase in the use of urine analysis and has become a part of any general health check up in the past decade. Increasing research activities in the field of urinalysis and growing awareness of personalized medicine have also resulted in the establishment point of care systems.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453